Valneva, a company specializing in vaccine development, reported strong financial results for the first quarter of 2024. The company achieved a significant year-over-year increase in product sales ...
Valneva, a company specializing in vaccine development, reported strong financial results for the first quarter of 2024. The company achieved a significant year-over-year increase in product sales, ...